Viewing Study NCT00028067


Ignite Creation Date: 2025-12-25 @ 12:52 AM
Ignite Modification Date: 2025-12-25 @ 11:07 PM
Study NCT ID: NCT00028067
Status: TERMINATED
Last Update Posted: 2011-05-04
First Post: 2001-12-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor
Sponsor: Bristol-Myers Squibb
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 302F
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators